These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25811549)

  • 1. A mathematical model of HTLV-I infection with two time delays.
    Lu X; Hui L; Liu S; Li J
    Math Biosci Eng; 2015 Jun; 12(3):431-49. PubMed ID: 25811549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability analysis of general delayed HTLV-I dynamics model with mitosis and CTL immunity.
    Elaiw AM; Shflot AS; Hobiny AD
    Math Biosci Eng; 2022 Aug; 19(12):12693-12729. PubMed ID: 36654018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A delayed HIV-1 model with virus waning term.
    Li B; Chen Y; Lu X; Liu S
    Math Biosci Eng; 2016 Feb; 13(1):135-57. PubMed ID: 26776264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of delay on HIV-1 dynamics of fighting a virus with another virus.
    Tian Y; Bai Y; Yu P
    Math Biosci Eng; 2014 Oct; 11(5):1181-98. PubMed ID: 25347812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission.
    Guo T; Qiu ZP
    Math Biosci Eng; 2019 Jul; 16(6):6822-6841. PubMed ID: 31698590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable and transient periodic oscillations in a mathematical model for CTL response to HTLV-I infection.
    Lang J; Li MY
    J Math Biol; 2012 Jul; 65(1):181-99. PubMed ID: 21792554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple stable periodic oscillations in a mathematical model of CTL response to HTLV-I infection.
    Li MY; Shu H
    Bull Math Biol; 2011 Aug; 73(8):1774-93. PubMed ID: 20976566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV-I infection: a dynamic struggle between viral persistence and host immunity.
    Lim AG; Maini PK
    J Theor Biol; 2014 Jul; 352():92-108. PubMed ID: 24583256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immune response to HTLV-1.
    Bangham CR; Osame M
    Oncogene; 2005 Sep; 24(39):6035-46. PubMed ID: 16155610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus dynamics model with intracellular delays and immune response.
    Song H; Jiang W; Liu S
    Math Biosci Eng; 2015 Feb; 12(1):185-208. PubMed ID: 25811332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection.
    Kannagi M; Matsushita S; Shida H; Harada S
    Leukemia; 1994 Apr; 8 Suppl 1():S54-9. PubMed ID: 8152305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
    J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global dynamics of an in-host viral model with intracellular delay.
    Li MY; Shu H
    Bull Math Biol; 2010 Aug; 72(6):1492-505. PubMed ID: 20087671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase.
    Biddison WE; Kubota R; Kawanishi T; Taub DD; Cruikshank WW; Center DM; Connor EW; Utz U; Jacobson S
    J Immunol; 1997 Aug; 159(4):2018-25. PubMed ID: 9257869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-I Infection: virus structure, immune response to the virus and genetic association studies in HTLV-I-infected individuals.
    Rafatpanah H; Farid R; Golanbar G; Jabbari Azad F
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):153-66. PubMed ID: 17237568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection.
    Brito-Melo GE; Peruhype-Magalhães V; Teixeira-Carvalho A; Barbosa-Stancioli EF; Carneiro-Proietti AB; Catalan-Soares B; Ribas JG; ; Martins-Filho OA
    Clin Exp Immunol; 2007 Jan; 147(1):35-44. PubMed ID: 17177961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.